Furthermore, 3-iodothyronamine (T1AM), an agonist of another member of the TAAR family, TAAR1, has been investigated as a potential anti-obesity drug affecting fatty acid catabolism and pyruvate toward gluconeogenesis in the liver and adipose tissue. This evidence concerns the gene TAAR1 and obesity disorder.